Detection of soluble HLA-G molecules in plasma and amniotic fluid - PubMed (original) (raw)
Detection of soluble HLA-G molecules in plasma and amniotic fluid
V Rebmann et al. Tissue Antigens. 1999 Jan.
Abstract
Although the cDNA sequence of HLA-G antigens is compatible with their expression as soluble molecules (sHLA-G), the determination of native sHLA-G levels in body fluids has not yet been described. The lack of this information is likely to reflect the difficulties in developing an assay suitable to measure sHLA-G antigens in the presence of soluble HLA-A, -B and -C (sHLA-I) antigens, since most of the available anti-HLA-G mAb do not detect soluble beta2-m associated HLA-G antigens or crossreact with sHLA-I antigens. Therefore, we have developed a two-step assay which eliminates the interference of classical HLA class I antigens. In the first step, the sample is depleted of sHLA-I antigens and of HLA-E antigens with mAb TP25.99. Then, HLA-G antigens are captured with mAb W6/32 and detected with anti-beta2-m mAb in ELISA. Utilizing this assay, sHLA-G antigen levels were measured in EDTA plasma from 92 controls with known HLA types, 28 women at delivery and the corresponding cord bloods and in 50 amniotic fluids. Mean sHLA-G plasma levels did not differ between males (24.9+/-3.0 SEM ng/ml; n=42) and females (20.1+/-2.1 SEM ng/ml; n = 50). However, sHLA-G levels in HLA-A11 positive probands (mean: 13.0+/-4.4 SEM ng/ml; n=12) were significantly (P<0.05) lower than in HLA-A11 negative ones (mean: 24.5+/-2.0 SEM ng/ml; n=80). sHLA-G levels in women at delivery (mean: 22.9+/-2.2 SEM ng/ml; n=28) were in the range of controls but were significantly (P<0.001) reduced in the corresponding cord bloods (mean: 13.8+/-1.5 SEM ng/ml; n=28). sHLA-G levels in amniotic fluids (mean: 15.5 + 1.0 SEM ng/ml; n=50) were significantly (P<0.001) lower than in plasma. sHLA-G levels were 5 and 11% of those of sHLA-I antigens in plasmas and amniotic fluids, respectively. Individual sHLA-G levels were not correlated with sHLA-I levels. SDS-PAGE analysis of plasma sHLA-G antigens revealed two molecular variants with a 35 kD and a 27 kD MW corresponding to the sizes of sHLA-G1 and -G2 isoforms. In conclusion, our study has shown that the two-step assay we have developed is reliable in measuring sHLA-G antigen levels. This assay will facilitate the analysis of the biological and clinical significance of sHLA-G antigens in plasma.
Similar articles
- Soluble HLA-G: purification from eukaryotic transfected cells and detection by a specific ELISA.
Fournel S, Aguerre-Girr M, Campan A, Salauze L, Berrebi A, Lone YC, Lenfant F, Le Bouteiller P. Fournel S, et al. Am J Reprod Immunol. 1999 Jul;42(1):22-9. doi: 10.1111/j.1600-0897.1999.tb00461.x. Am J Reprod Immunol. 1999. PMID: 10429763 - Quantification and identification of soluble HLA-G isoforms.
Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED, Grosse-Wilde H. Rebmann V, et al. Tissue Antigens. 2007 Apr;69 Suppl 1:143-9. doi: 10.1111/j.1399-0039.2006.763_5.x. Tissue Antigens. 2007. PMID: 17445190 - HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.
Hackmon R, Hallak M, Krup M, Weitzman D, Sheiner E, Kaplan B, Weinstein Y. Hackmon R, et al. Fetal Diagn Ther. 2004 Sep-Oct;19(5):404-9. doi: 10.1159/000078992. Fetal Diagn Ther. 2004. PMID: 15305096 - HLA-G in reproduction: studies on the maternal-fetal interface.
Hunt JS, Petroff MG, Morales P, Sedlmayr P, Geraghty DE, Ober C. Hunt JS, et al. Hum Immunol. 2000 Nov;61(11):1113-7. doi: 10.1016/s0198-8859(00)00195-6. Hum Immunol. 2000. PMID: 11137215 Review. - Soluble HLA-G: Are they clinically relevant?
Pistoia V, Morandi F, Wang X, Ferrone S. Pistoia V, et al. Semin Cancer Biol. 2007 Dec;17(6):469-79. doi: 10.1016/j.semcancer.2007.07.004. Epub 2007 Jul 31. Semin Cancer Biol. 2007. PMID: 17825579 Free PMC article. Review.
Cited by
- HLA-G Expression/Secretion and T-Cell Cytotoxicity in Missed Abortion in Comparison to Normal Pregnancy.
Terzieva A, Alexandrova M, Manchorova D, Slavov S, Djerov L, Dimova T. Terzieva A, et al. Int J Mol Sci. 2024 Feb 24;25(5):2643. doi: 10.3390/ijms25052643. Int J Mol Sci. 2024. PMID: 38473890 Free PMC article. - Predictive Capabilities of Human Leukocyte Antigen-G and Galectin-13 Levels in the Amniotic Fluid and Maternal Blood for the Pregnancy Outcome.
Vincze M, Sikovanyecz J Jr, Molnár A, Földesi I, Surányi A, Várbíró S, Németh G, Sikovanyecz J, Kozinszky Z. Vincze M, et al. Medicina (Kaunas). 2024 Jan 1;60(1):85. doi: 10.3390/medicina60010085. Medicina (Kaunas). 2024. PMID: 38256346 Free PMC article. - Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis.
Amoriello R, Rizzo R, Mariottini A, Bortolotti D, Gentili V, Bonechi E, Aldinucci A, Carnasciali A, Peruzzi B, Repice AM, Massacesi L, Fainardi E, Ballerini C. Amoriello R, et al. Front Neurol. 2022 May 25;13:872396. doi: 10.3389/fneur.2022.872396. eCollection 2022. Front Neurol. 2022. PMID: 35693002 Free PMC article. - The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design.
Kessler AL, Bruno MJ, Buschow SI. Kessler AL, et al. Vaccines (Basel). 2020 Dec 18;8(4):775. doi: 10.3390/vaccines8040775. Vaccines (Basel). 2020. PMID: 33353014 Free PMC article. Review. - Roles of HLA-G in the Maternal-Fetal Immune Microenvironment.
Xu X, Zhou Y, Wei H. Xu X, et al. Front Immunol. 2020 Oct 22;11:592010. doi: 10.3389/fimmu.2020.592010. eCollection 2020. Front Immunol. 2020. PMID: 33193435 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials